Clinical Trial

Association of Body Fluid Distribution With Obstructive Sleep Apnea in Pregnant Women With Body Mass Index ≥ 40 kg/m2

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Obstructive Sleep apnea (OSA) is a common and underdiagnosed condition in obese pregnant women with serious and life-threatening complications to the mother and baby. The investiators propose that a non-invasive method may be used to detect patients at risk of OSA, giving these women access to the necessary treatment to treat this condition. The method is a estimation of body water, which has been shown to be linked to OSA in the non-pregnant population. Body water is estimated by applying surface electrodes to a participant who is lying down by measuring bioimpedance through body tissues by applying a tiny current between the electrodes. The electrical stimulation is not felt by the participant and has no negative effects on mother or baby.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2019-12-04; most recent amendment 2026-03-31.
Status change: Recruiting → Active, Not Recruiting 2024-03-05
Status change: Suspended → Recruiting 2022-12-16
Status change: Recruiting → Suspended 2021-01-04
Trial Details
NCT Number NCT04187612
Lead Sponsor Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Conditions Apnea, Obstructive Sleep, Obesity
Enrollment 52 participants
Start Date 2019-12-02
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-06